| 2024-02-02 | Sale | EyePoint Pharmaceuticals, Inc. EYPT | SVP & Chief Commercial Officer | 209 0.0007% | $28.49 | $5,954 | -29.36% | |
| 2024-01-26 | Sale | EyePoint Pharmaceuticals, Inc. EYPT | SVP & Chief Commercial Officer | 26,017 0.0509% | $25.38 | $660,370 | -22.63% | |
| 2024-01-25 | Sale | EyePoint Pharmaceuticals, Inc. EYPT | SVP & Chief Commercial Officer | 600 0.0012% | $25.00 | $15,000 | -17.25% | |
| 2024-01-24 | Sale | EyePoint Pharmaceuticals, Inc. EYPT | SVP & Chief Commercial Officer | 11,300 0.0335% | $25.01 | $282,621 | -13.67% | |
| 2024-01-23 | Sale | EyePoint Pharmaceuticals, Inc. EYPT | SVP & Chief Commercial Officer | 900 0.0026% | $25.00 | $22,500 | -16.71% | |
| 2024-01-22 | Sale | EyePoint Pharmaceuticals, Inc. EYPT | SVP & Chief Commercial Officer | 34,166 0.0914% | $22.62 | $772,691 | -13.32% |